About Molecular Diagnostics
The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. Wide scope of application, specificity, and quick turnaround time are factors that are contributing to its importance in the IVD market.
Technavio’s analysts forecast the global molecular diagnostics market to grow at a CAGR of 10.38% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global molecular diagnostics market for 2016-2020. To calculate the market size, revenue generated from the sales of equipment such as automated real-time PCR, mass spectroscopy, and DNA sequencing and DNA microarray diagnostic devices, consumables, and reagents is considered.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Molecular Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Hologic Inc.
• Qiagen
• Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd.)
• Siemens Healthcare GmbH
Other prominent vendors
• AsuraGen
• Ahram Biosystem
• Analytik Jena
• BD
• Bio-Rad
• EKF Molecular Diagnostics
• EMD Millipore
• HTG Molecular
• InBios International
• Maxim Biomedical
• Mindray
• Myriad Genetics
• Ortho Clinical Diagnostics
• Ras Lifesciences
• Trivitron Healthcare
• ThermoFisher Scientific
Market driver
• Key to cost-effective diagnosis of cancer
• For a full, detailed list, view our report
Market challenge
• Reimbursement issues
• For a full, detailed list, view our report
Market trend
• Growth of theranostics
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Companion diagnostics: Promising business model
• Reimbursement scenario
PART 06: Perspective of LDTs in US
• Requirement of regulatory framework
• Post implementation scenario
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by application
• Global molecular diagnostics market by infectious disease testing
• Global molecular diagnostics market by oncological testing
• Global molecular diagnostics market by blood testing
• Global molecular diagnostics market by genetic testing
• Global molecular diagnostics market by tissue typing
PART 09: Geographical segmentation
• Molecular diagnostics market in Americas
• Molecular diagnostics market in EMEA
• Molecular diagnostics market in APAC
PART 10: Market drivers
• Key to cost-effective diagnosis of cancer
• Development of molecular POCT
• Increase in investments in genomics and proteomics research
PART 11: Impact of drivers
PART 12: Market challenges
• Reimbursement issues
• Threat of low-cost products
• Issues with quality control and cold chain management
• Ethical issues associated with DTC genetic testing
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Growth of theranostics
• Development of NGS technology and DNA arrays
• Increase in partnerships
• Development of personalized medicine
PART 15: Vendor landscape
• Abbott Diagnostics
• Hologic
• Qiagen
• Roche Diagnostics
• Siemens Healthcare
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
?
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Examples of approved companion diagnostics
Exhibit 03: Companion diagnostics coverage in the US
Exhibit 04: Global molecular diagnostics market 2015-2020 ($ billions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global molecular diagnostics market by application 2015
Exhibit 07: Global molecular diagnostics market by infectious disease testing 2015-2020 ($ billions)
Exhibit 08: Global molecular diagnostic market by oncological testing 2015-2020 ($ billions)
Exhibit 09: Global molecular diagnostics market by blood testing 2015-2020 ($ billions)
Exhibit 10: Global molecular diagnostics market by genetic testing 2015-2020 ($ billions)
Exhibit 11: Global molecular diagnostics market by tissue typing 2015-2020 ($ millions)
Exhibit 12: Segmentation of global molecular diagnostics market by geography 2015
Exhibit 13: Molecular diagnostics market in Americas 2015-2020 ($ billions)
Exhibit 14: Molecular diagnostics market in EMEA 2015-2020 ($ billions)
Exhibit 15: Molecular diagnostics market in APAC 2015-2020 ($ billions)
Exhibit 16: Impact of drivers
Exhibit 17: Impact of drivers and challenges
Exhibit 18: Global molecular diagnostics market by vendors 2014 and 2015
Exhibit 19: Key molecular diagnostic product launches by Roche and Qiagen 2015
Exhibit 20: Key takeaways: Abbott Diagnostics
Exhibit 21: Key takeaways: Hologic
Exhibit 22: Key takeaways: Qiagen
Exhibit 23: Key takeaways: Roche Diagnostics
Exhibit 24: Key takeaways: Siemens Healthcare
